| Title | Licenses; Exemptions, Applications, Amendments etc.: Imidazo-Pyrazine Scaffold Core for the Treatment or Prevention of Cancers Expressing the Mannose Receptor CD206, Including Both Solid Tumors and Hematological Malignancies |
| ToC Doc | Imidazo-Pyrazine Scaffold Core for the Treatment or Prevention of Cancers Expressing the Mannose Receptor CD206, Including Both Solid Tumors and Hematological Malignancies |
| Docket Number | 2022-04829 |
| Type | Notice |
| Subject | Licenses; Exemptions, Applications, Amendments etc.: Imidazo-Pyrazine Scaffold Core for the Treatment or Prevention of Cancers Expressing the Mannose Receptor CD206, Including Both Solid Tumors and Hematological Malignancies |
| Publication Date | 2022-03-08 |
| Last Updated Date | 2022-03-07 08:15:08 -0500 |
| Last Public Inspection | 2022-03-07 |
| Filed At | 2022-03-07T08:45:00.000-05:00 |
| 2022-04829_PI.pdf (89627 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 3 |
| Filing Type | regular |
| Agencies | National Institutes of Health |
You can find the raw source document below...